Logo image of SLI

STANDARD LITHIUM LTD (SLI) Stock Fundamental Analysis

NYSEARCA:SLI - NYSE Arca - CA8536061010 - Common Stock - Currency: USD

1.88  +0.13 (+7.43%)

After market: 1.88 0 (0%)

Fundamental Rating

3

SLI gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 154 industry peers in the Metals & Mining industry. While SLI has a great health rating, there are worries on its profitability. SLI does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

SLI had negative earnings in the past year.
In the past year SLI has reported a negative cash flow from operations.
In the past 5 years SLI reported 4 times negative net income.
In the past 5 years SLI always reported negative operating cash flow.
SLI Yearly Net Income VS EBIT VS OCF VS FCFSLI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M

1.2 Ratios

SLI has a better Return On Assets (36.58%) than 98.05% of its industry peers.
The Return On Equity of SLI (41.36%) is better than 97.40% of its industry peers.
Industry RankSector Rank
ROA 36.58%
ROE 41.36%
ROIC N/A
ROA(3y)-2.71%
ROA(5y)-11.79%
ROE(3y)-1.78%
ROE(5y)-12.36%
ROIC(3y)N/A
ROIC(5y)N/A
SLI Yearly ROA, ROE, ROICSLI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50 -100 -150

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for SLI so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
SLI Yearly Profit, Operating, Gross MarginsSLI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024

More info and screens

8

2. Health

2.1 Basic Checks

The number of shares outstanding for SLI has been increased compared to 1 year ago.
The number of shares outstanding for SLI has been increased compared to 5 years ago.
Compared to 1 year ago, SLI has an improved debt to assets ratio.
SLI Yearly Shares OutstandingSLI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
SLI Yearly Total Debt VS Total AssetsSLI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

2.2 Solvency

SLI has an Altman-Z score of 6.43. This indicates that SLI is financially healthy and has little risk of bankruptcy at the moment.
SLI has a better Altman-Z score (6.43) than 77.92% of its industry peers.
The Debt to FCF ratio of SLI is 0.02, which is an excellent value as it means it would take SLI, only 0.02 years of fcf income to pay off all of its debts.
SLI's Debt to FCF ratio of 0.02 is amongst the best of the industry. SLI outperforms 95.45% of its industry peers.
SLI has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
With an excellent Debt to Equity ratio value of 0.00, SLI belongs to the best of the industry, outperforming 85.06% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.02
Altman-Z 6.43
ROIC/WACCN/A
WACCN/A
SLI Yearly LT Debt VS Equity VS FCFSLI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M

2.3 Liquidity

SLI has a Current Ratio of 6.52. This indicates that SLI is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 6.52, SLI belongs to the top of the industry, outperforming 87.01% of the companies in the same industry.
SLI has a Quick Ratio of 6.52. This indicates that SLI is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of SLI (6.52) is better than 87.01% of its industry peers.
Industry RankSector Rank
Current Ratio 6.52
Quick Ratio 6.52
SLI Yearly Current Assets VS Current LiabilitesSLI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

More info and screens

1

3. Growth

3.1 Past

SLI shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -23.75%.
EPS 1Y (TTM)-23.75%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%30%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

SLI is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 21.35% yearly.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y75.37%
EPS Next 2Y28.35%
EPS Next 3Y16.01%
EPS Next 5Y21.35%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
SLI Yearly Revenue VS EstimatesSLI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2028 2029 50M 100M 150M 200M 250M
SLI Yearly EPS VS EstimatesSLI Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 0 0.2 -0.2 -0.4

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

SLI reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for SLI. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
SLI Price Earnings VS Forward Price EarningsSLI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20

4.2 Price Multiples

Based on the Price/Free Cash Flow ratio, SLI is valued cheaply inside the industry as 87.01% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 15.29
EV/EBITDA N/A
SLI Per share dataSLI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1

4.3 Compensation for Growth

A more expensive valuation may be justified as SLI's earnings are expected to grow with 16.01% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y28.35%
EPS Next 3Y16.01%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for SLI!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

STANDARD LITHIUM LTD

NYSEARCA:SLI (6/16/2025, 8:08:38 PM)

After market: 1.88 0 (0%)

1.88

+0.13 (+7.43%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)05-09 2025-05-09/bmo
Earnings (Next)N/A N/A
Inst Owners7.56%
Inst Owner Change0%
Ins Owners3.08%
Ins Owner Change0%
Market Cap364.61M
Analysts83.64
Price Target2.94 (56.38%)
Short Float %4.11%
Short Ratio2.93
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-162.96%
Min EPS beat(2)-394.26%
Max EPS beat(2)68.35%
EPS beat(4)2
Avg EPS beat(4)-126.7%
Min EPS beat(4)-394.26%
Max EPS beat(4)68.35%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-6.02%
PT rev (3m)-6.6%
EPS NQ rev (1m)4.56%
EPS NQ rev (3m)4.56%
EPS NY rev (1m)0%
EPS NY rev (3m)23.39%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF 15.29
P/OCF N/A
P/B 1.55
P/tB 1.56
EV/EBITDA N/A
EPS(TTM)-0.4
EYN/A
EPS(NY)-0.16
Fwd EYN/A
FCF(TTM)0.12
FCFY6.54%
OCF(TTM)-0.01
OCFYN/A
SpS0
BVpS1.21
TBVpS1.21
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 36.58%
ROE 41.36%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-2.71%
ROA(5y)-11.79%
ROE(3y)-1.78%
ROE(5y)-12.36%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.02
Debt/EBITDA N/A
Cap/Depr 21896.6%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality 24.54%
Current Ratio 6.52
Quick Ratio 6.52
Altman-Z 6.43
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)3831.29%
Cap/Depr(5y)2403.6%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-23.75%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%30%
EPS Next Y75.37%
EPS Next 2Y28.35%
EPS Next 3Y16.01%
EPS Next 5Y21.35%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y52.18%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year6.81%
EBIT Next 3Y16.22%
EBIT Next 5Y41.04%
FCF growth 1Y147.87%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y81.33%
OCF growth 3YN/A
OCF growth 5YN/A